Axa’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-91,351
| Closed | -$1.32M | – | 1115 |
|
|
2022
Q1 | $1.32M | Sell |
91,351
-43,251
| -32% | -$623K | ﹤0.01% | 909 |
|
|
2021
Q4 | $7.03M | Sell |
134,602
-24,233
| -15% | -$1.26M | 0.02% | 578 |
|
|
2021
Q3 | $9.26M | Sell |
158,835
-4,716
| -3% | -$275K | 0.03% | 518 |
|
|
2021
Q2 | $13.2M | Buy |
163,551
+914
| +0.6% | +$73.7K | 0.04% | 458 |
|
|
2021
Q1 | $13.5M | Sell |
162,637
-3,269
| -2% | -$272K | 0.04% | 446 |
|
|
2020
Q4 | $12.6M | Sell |
165,906
-14,174
| -8% | -$1.07M | 0.04% | 442 |
|
|
2020
Q3 | $19.2M | Sell |
180,080
-23,961
| -12% | -$2.55M | 0.07% | 294 |
|
|
2020
Q2 | $30.9M | Buy |
204,041
+4,225
| +2% | +$641K | 0.12% | 199 |
|
|
2020
Q1 | $16.6M | Sell |
199,816
-4,468
| -2% | -$372K | 0.08% | 250 |
|
|
2019
Q4 | $34.5M | Buy |
204,284
+25,041
| +14% | +$4.23M | 0.14% | 183 |
|
|
2019
Q3 | $33.3M | Buy |
179,243
+2,992
| +2% | +$556K | 0.13% | 204 |
|
|
2019
Q2 | $40.3M | Buy |
176,251
+132,624
| +304% | +$30.3M | 0.16% | 181 |
|
|
2019
Q1 | $9.17M | Sell |
43,627
-3,860
| -8% | -$811K | 0.04% | 475 |
|
|
2018
Q4 | $5.46M | Buy |
47,487
+7,117
| +18% | +$818K | 0.02% | 579 |
|
|
2018
Q3 | $9.27M | Buy |
40,370
+2,322
| +6% | +$533K | 0.03% | 500 |
|
|
2018
Q2 | $8.49M | Buy |
38,048
+6,796
| +22% | +$1.52M | 0.03% | 502 |
|
|
2018
Q1 | $7.14M | Buy |
31,252
+150
| +0.5% | +$34.3K | 0.03% | 550 |
|
|
2017
Q4 | $8.15M | Sell |
31,102
-12,163
| -28% | -$3.19M | 0.03% | 532 |
|
|
2017
Q3 | $9.71M | Buy |
43,265
+12,404
| +40% | +$2.78M | 0.04% | 444 |
|
|
2017
Q2 | $8.44M | Buy |
+30,861
| New | +$8.44M | 0.04% | 463 |
|